In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sutura's SuperStitch EL reaches PFO (patent foramen ovale) human trials

This article was originally published in Clinica

Executive Summary

Following the news earlier this month of its testing in porcine hearts (see Clinica No 1267, p 18), Sutura's SuperStitch EL minimally-invasive suturing device has been used for the first time in a human patient. The device delivered a suture to the septum that separates the left and right atria of the heart, to close a patent foramen ovale (PFO).






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts